Zeitungsständer (Symbolbild).
Quelle: © Global_Pics / iStock Unreleased / Getty Images
Google
neu
Die Newsartikel wurden besser lesbar gestaltet.
Mehr erfahren
PR Newswire  | 

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DCPH, IONM, DPSI

PR Newswire

Anhören
Teilen
Feedback
Kopieren
ARIVA Newsletter
Assure Holdings Corp 0,01 $ Assure Holdings Corp Chart +999.900,0%
Deciphera Pharmaceuticals Inc -   Deciphera Pharmaceuticals Inc Chart 0,00%
DecisionPoint Systems -   DecisionPoint Systems Chart 0,00%

NEW YORK, May 10, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH)'s sale to ONO Pharmaceutical Co., Ltd. for $25.60 per share in cash. If you are a Deciphera shareholder, click here to learn more about your rights and options.

Assure Holdings Corp. (NASDAQ: IONM)'s merger with Danam Health, Inc. Upon completion of the proposed transaction, current Assure shareholders are expected to own approximately 10% of the combined company. If you are an Assure shareholder, click here to learn more about your rights and options.

DecisionPoint Systems, Inc. (NYSE: DPSI)'s sale to an affiliate of Barcoding Holdings, LLC for $10.22 in cash per share. If you are a DecisionPoint shareholder, click here to learn more about your rights and options.

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-dcph-ionm-dpsi-302142401.html

SOURCE Halper Sadeh LLP


Community-Beiträge zu Deciphera Pharmaceuticals Inc

aus Forum-Thread: DCPH 36,72$ (+84%)
Avatar des Verfassers
29.04.2024 - 14:54 Uhr
Vassago
DCPH 25.04$ (vorbörslich +71%)
Ãœbernahme durch ONO Pharmaceuticals 2,4 Mrd. $ Deal ONO zahlt 25,60$ in Cashdie Ãœbernahme soll in Q3/24 abgeschlossen werden https://www.xm.com/research/markets/allNews/reuters/deciphera-pharma-rises-as-co-to-be-acquired-by-ono-pharmaceutical-for-24-bln-53824835
Avatar des Verfassers
19.01.2023 - 15:54 Uhr
Vassago
DCPH 17.40$ (-16%)
125 Mio. $ Offering geplant https://investors.deciphera.com/news-releases/news-release-details/deciphera-pharmaceuticals-announces-proposed-public-offering-3
Jetzt anmelden und diskutieren Registrieren Login

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.